Security key
52635N103
LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ)
CUSIP: 52635N103
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 16,171,755
- Total 13F value
- $361,085,230
- Share change
- +16,155,534
- SEC-reported price per share
- $22.33
- Number of holders
- 54
- Value change
- +$360,723,016
- Number of buys
- 53
- Shares outstanding
- 31,441,412
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
54
Top holders
10
LENZ full security history
Ownership snapshot
Full 13F holder table
LENZ Therapeutics, Inc. SEC filings
LENZ Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of LENZ - LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
0/15
Latest evidence
21 Mar 2024
3/4/5
Highest disclosed value: $34,836,860
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
EcoR1 Capital, LLC has the largest disclosed position value at $34.84M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EcoR1 Capital, LLC's linked filing trail.
Disclosed position value
Top 5
EcoR1 Capital, LLC
$34.84M
Samsara BioCapital, L.P.
$34.67M
Versant Venture Capital VII, L.P.
$6.52M
Phil Gutry
$1.22M
Katherine V Stultz
$881.4K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$34,836,860
8,538,446 shares
|
— | 06 Jan 2023 |
| Samsara BioCapital, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$34,668,033
8,497,067 shares
|
— | 11 Apr 2022 |
| Versant Venture Capital VII, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$6,523,059
1,598,789 shares
|
— | 21 Mar 2024 |
| Alpha Wave Ventures GP, Ltd |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
3,612,211 shares
|
— | 21 Mar 2024 |
| Phil Gutry |
3/4/5
CHIEF BUSINESS OFFICER
|
—
class O/S missing
|
$1,223,759
299,941 shares
|
— | 11 Apr 2022 |
| Katherine V Stultz |
3/4/5
CHIEF OPERATING OFFICER
|
—
mixed-class rows
|
$881,362
305,954 shares
mixed-class rows
|
— | 24 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
54
Shares
16,171,755
Rows available
54
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
54
Q1 2024 holders
54
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|